Page 2 - CUA KIDNEY CANCER HANDBOOK 2020
P. 2
This booklet has been made possible through funding from
Bristol-Myers Squibb Canada Co. and Merck Canada Inc.
in the form of educational grants. Pfizer Oncology as a contributor.
Editors
Daniel Y. C. Heng, MD, MPH, FRCPC
Clinical Professor
Department of Medical Oncology, University of Calgary
Staff Medical Oncologist
Tom Baker Cancer Center, Calgary
Christian Kollmannsberger, MD, FRCPC
Clinical Professor of Medicine
Division of Medical Oncology, University of British Columbia
Medical Oncologist
BC Cancer – Vancouver Cancer Centre
Contributors
Ricardo Rendon, MD, FRCSC
Professor, Department of Urology
Nova Scotia Health Authority & Dalhousie University
Chair, Genitourinary Cancer Site Team,
Nova Scotia Health Authority Cancer Program
VP Education, Canadian Urological Association
Anil Kapoor, MD, FRCSC
Professor of Surgery (Urology)
McMaster University
Director, Urologic Cancer Center for Research & Innovation
Head, Genito-Urinary Oncology Program
Juravinski Cancer Centre, Hamilton
CUA CEO
Tiffany Pizioli, MBA
Canadian Urological Association
185 Dorval Ave., Suite 401
Dorval, QC, Canada H9S 5J9
